Company / Operating Cash Flow per Share
Harmony Biosciences Holdings, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$6.09
FY2025
5-year range
-$1.33 / $6.09
FY2021-FY2025
Trend
+57.4%
vs FY2024
Sector context
#21 of 212
Health Care
What the data says
Among 212 Health Care companies, Harmony Biosciences Holdings, Inc. is in the top 10% for operating cash flow per share. Operating Cash Flow per Share has increased for 6 consecutive years, from $-9.70 in FY2019 to $6.09 in FY2025.
Based on SEC 10-K filings.
6.09 in FY2025 with a 3-year CAGR of +35.4%. Top quartile in the Health Care sector.
Improved from $3.68 to $6.09 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +35.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+15.5% above sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s operating cash flow per share has grown for 6 consecutive years.
- In FY2025, operating cash flow per share increased 57.4% year-over-year.
- Ranks #21 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.09 | +57.4% |
| FY2024 | $3.87 | +5.2% |
| FY2023 | $3.68 | +49.8% |
| FY2022 | $2.46 | +285.2% |
| FY2021 | -$1.33 | +86.3% |
| FY2020 | -$9.69 | +0.1% |
| FY2019 | -$9.70 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026